학술논문

Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study
Document Type
Journal
Source
RMD OPEN; FEB 2022, 8 1, pe002012 12p.
Subject
Language
English
ISSN
20565933